Legal & General Group PLC Logic Bio Therapeutics, Inc. Transaction History
Legal & General Group PLC
- $470 Billion
- Q3 2024
Shares
7 transactions
About LogicBio Therapeutics, Inc.
- Ticker LOGC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,962,700
- Description
- LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...